Peptide with anti-obesity action successfully tested in animal trial

A study conducted at the University of São Paulo (USP) in Brazil shows that the synthetic molecule Pep19 acts on the endocannabinoid system, which helps regulate and balance key metabolic functions, such as appetite, fat breakdown (lipolysis), and energy release.

This article was originally published on MedicalXpress.com

You may also be interested in:

Read More:

Lawyers Lookup